Today is National Wear Gray Day for Brain Tumor Awareness Month, a day that is at the heart of what we do at IN8bio. 🩶🎗️
We wear gray to stand in solidarity and honor the resilience of these patients, their families, healthcare providers, and community outreach programs fighting alongside them.
We see you and are fighting for better treatments, better outcomes, and better funding for Glioblastoma (GBM) treatments.
#CancerZero #WearGrayDay #GoGrayInMay $INAB
2
4
166
May 9
Séance de travail sur les enjeux, la vision et l’architecture globale du projet #CancerZero, le vendredi matin à l’Ambassade du Gabon en Belgique avec le Professeur Moez BEN ALI, Responsable du Projet CancerZéro (@Moez Benali). Opportunité de revenir sur l’importance de la santé pour le développement, d’aborder l’amélioration de l’Institut de Cancérologie d’Agondje, de l’approche mondiale de lutte contre le cancer, d’aborder les différents écueils qui freinent l’accès aux médicaments en Afrique, du transfert de connaissance et du sommet mondial contre le cancer du 17 octobre à Tunis dont le Gabon y est invité. La lutte contre le fléau du Cancer est primordiale. L’afropessisme n’a pas sa place à ce niveau.
@GabonBelgique @PresidenceGabon
1
10
309
Ce 08/05/26, S.E.M. @ImmongaultR a échangé avec le Pr Moez Ben Ali sur le projet #CancerZero et les défis de l’accès aux traitements anticancéreux en Afrique.
Face au fléau du cancer, une mobilisation internationale et une Afrique plus coordonnée sont indispensables.
1
2
72
We are happy to announce that our President & COO, Dr. Kate Rochlin, will present at the Festival of Biologics USA 2026 on March 4th, at 12:30 pm PST.
She will present on “Activating the Potential of Gamma Delta T-Cells: A Next-Generation TCE for Autoimmune & Oncology.”
$INAB #CancerZero
1
2
4
403
🎗️El proyecto #cAncerZero impulsado por @AstraZenecaES reĂşne a expertos en oncologĂa, representantes de pacientes y sociedades cientĂficas
👉@JAVIERDECASTROF de @_SEOM, @LauraColonMd, Dolores Lozano de @SEAP_IAP y @Pilar_Ferpas de @almiamc
cancermetastasico.es/proyect…
6
9
443
📰Proyecto #cAncerZero | Proyecto cAncer Zero, la apuesta de @AstraZenecaES por alcanzar un futuro sin muertes por cáncer
@Pilar_Ferpas @LauraColonMd @mdlozanoe @javierDcastro
consalud.es/Especiales/dia-m…
3
7
259
đź“°Proyecto #cAncerZero | ÂżLlegará el dĂa en el que el cáncer no cause muertes? @larazon_es
@AstraZenecaES @Pilar_Ferpas @LauraColonMd @mdlozanoe @javierDcastro
larazon.es/salud/llegara-dia…
3
6
167
🎗️ Con motivo del #DĂaMundialContraElCáncer nuestra presidenta @Pilar_Ferpas recuerda la importancia de la investigaciĂłn
👉 @almiamc colabora con @AstraZenecaES en el proyecto #cAncerZero
astrazeneca.es/areas-terapeu…
2
3
93
Hablar de cáncer es hablar de personas y de cĂłmo las acompañamos. Hoy tambiĂ©n, junto a @LauraColonMd, @Monica_Garcia_G y @RaquelYotti, en el acto institucional #DĂaMundialContraElCáncer @ContraCancerEs, que ha presidido SM la Reina, doña Letizia.
#cAncerZero
3
104
Estamos ante un cambio de paradigma en oncologĂa. La anatomĂa patolĂłgica vive una revoluciĂłn impulsada por la patologĂa digital y computacional y la IA.
Lee el artĂculo de la Dra. @mdlozanoe, presidenta de @SEAP_IAP en este enlace: astrazeneca.es/areas-terapeu…
#cAncerZero
4
4
532
Con motivo del #DĂaMundialContraElCáncer, @Pilar_Ferpas, presidenta de Alianza frente a la Metástasis: InnovaciĂłn y Apoyo (ALMIA), recuerda que el cáncer metastásico no es el final, sino el comienzo de una nueva forma de vivir.
Conoce más sobre nuestra ambición #cAncerZero👉 astrazeneca.es/areas-terapeu…
3
6
425
Con motivo del #DĂaMundialContraElCáncer, reafirmamos nuestra ambiciĂłn: un futuro con #cAncerZero.
@LauraColonMd, presidenta de AstraZeneca España, comparte su visión sobre los avances que están transformando la vida de los pacientes.
Conoce más: astrazeneca.es/areas-terapeu…
2
9
1,078
IN8bio’s updated Phase I/II data show significant and durable survival improvements for patients with newly diagnosed Glioblastoma.Â
Read more about our investigational therapy, DeltEx™ Drug-Resistant Immunotherapy gamma-delta (γδ) T cells (DeltEx DRI).
Full press release here: bit.ly/4qIig0y
#CancerZero #GBM $INAB
1
8
301
IN8bio Announces Pricing of Private Placement of up to $40.2 Million.
Financing led by Coastlands Capital with participation from new and existing biotechnology investors.
$20.1 million upfront with a milestone-driven additional $20.1 million to advance INB-619, IN8bio’s novel gamma-delta (“γδ”) T cell engager through an Investigational New Drug (“IND”) application.
Read the full press release: bit.ly/4apRHsg
$INAB #CancerZero #GDTCells
1
3
7
503
IN8bio is proud to announce that The Ohio State University has been added as a new clinical site in the ongoing Phase 1 trial of the INB-100, an allogeneic gamma-delta T cell therapy for patients with complex leukemia.
To date this trial has demonstrated long-term remission and survival in patients with high-risk disease, with the earliest treated patients beyond 4 and 5 years relapse-free. With multiple sites screening, we look forward to completing the enrollment of the study expansion cohort and releasing follow-up data next year.Â
Read more: investors.in8bio.com/news-re…
#CancerZero $INAB
2
8
697
IN8bio presented data demonstrating the power of INB-619, a γδ T cell Engager, to drive complete B cell depletion in preclinical Lupus (SLE) donor models.Â
This data highlights the potential to transform the treatment of autoimmune diseases by harnessing the unique properties of γδ T cells to safely and precisely eliminate pathogenic B cells.
Read more: investors.in8bio.com/news-re…
$INAB #CancerZero
1
7
1,306
IN8bio Presents New T Cell Engager (TCE) Data Demonstrating Deep B Cell Depletion for Autoimmune Indications. INB-619 is a CD19-targeted, pan-γδ T cell engager designed to activate and expand γδ T cells to drive deep target cell depletion.
The data is being presented today at the 2025 American College of Rheumatology (ACR) Convergence Meeting in Chicago.
Read the full press release and view our virtual poster: investors.in8bio.com/news-re…
$INAB #ACR25 #CancerZero
2
10
1,000
Adrian Hayday, one of the pioneers of γδ T cell biology, highlights what makes these cells so unique: their natural ability to discriminate cancer from healthy tissue.
This biology is the foundation of IN8bio’s platform and why we believe γδ T cells represent the next major frontier in immunotherapy.
 #CancerZero $INAB
25 Oct 2025
γδ T cells are a unique population of immune cells that can recognize and kill tumors.
A 2024 #ScienceReview explores current research efforts focused on how γδ cells naturally discriminate cancers from healthy tissues. scim.ag/3L69yts #ScienceMagArchives
2
8
1,193
IN8bio is proud to attend BIO Alabama in Birmingham, home of our R&D and manufacturing facility!
Our CEO & co-founder, William Ho, will present today at 9:45 a.m. CST. We are also happy to have our CSO & co-founder, Lawrence Lamb, PhD, in attendance!
@bioalabama #BioAlabama #ALBioTech #CancerZero #IN8bio $INAB
2
5
301
“On a scale of 1 to 10—and it’s a 12—it’s glioblastoma.” @DrVickersMSK, CEO of @MSKCancerCenter, discussing the deadliest cancers on @Bloomberg’s fantastic new “Longevity” series with @DM_Rubenstein.Â
Thanks to Dr. Vickers for helping to launch our first GBM trial while he was at UAB!
Â
Our INB-200 program is uniquely designed to take on GBM and bring new hope to patients. Â
Â
$INAB #CancerZero #GBM @NBTStweets @UABNews @uabmedicine
9
339